metabion

metabion announced on July 11, 2023 that it has completed a double-digit million euro investment in the first quarter of 2023 to expand its oligonucleotide manufacturing capacity at a new facility in Munich East, Germany. The facility serves diagnostic and therapeutic oligonucleotide production.